全球数位呼吸设备市场

预计到 2030 年全球数位呼吸器市场规模将达到 3,133 亿美元

全球数位呼吸设备市场规模预计在2024年达到745亿美元，预计在2024-2030年的分析期内将以27.0%的复合年增长率增长，到2030年将达到3133亿美元。智慧吸入器和雾化器是本报告分析的细分市场之一，预计其复合年增长率将达到29.8%，到分析期结束时规模将达到2,217亿美元。感测器和应用程式细分市场在分析期间的复合年增长率预计将达到21.7%。

美国市场规模估计为 203 亿美元，中国市场预计复合年增长率为 36.0%

美国数位呼吸器市场规模预计在2024年达到203亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到791亿美元，在2024-2030年的分析期间内，复合年增长率为36.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为21.5%和24.5%。在欧洲，预计德国市场的复合年增长率约为22.9%。

全球数位呼吸机市场—主要趋势与驱动因素摘要

数位呼吸器可以改善慢性病管理吗？

气喘、慢性阻塞性肺病(COPD) 和肺纤维化等呼吸系统疾病的盛行率不断上升，推动了数位呼吸器的普及，彻底改变了患者监测和治疗依从性。传统的吸入器和肺计量计如今整合了数位感测器、蓝牙连接和云端基础分析功能，可以即时追踪肺功能、药物剂量和症状模式。智慧吸入器结合了人工智慧药物依从性追踪技术，可以提醒患者和医护人员漏服药物，确保更有效地管理疾病。此外，穿戴式呼吸监测器和远端肺量计解决方案使肺科医生能够远端评估患者的肺部健康状况，减少住院和急诊就诊次数。然而，儘管数位呼吸机提供了更高的便利性和准确性，但对资料安全性、设备价格以及与电子健康记录(EHR) 整合的担忧仍然是关键挑战。儘管存在这些障碍，但对数位呼吸机解决方案的需求预计仍将增长，尤其是在医疗保健系统越来越重视远端患者监测和个人化治疗策略的情况下。

人工智慧和物联网如何塑造呼吸照护的未来？

人工智慧 (AI) 和物联网 (IoT) 透过实现预测分析、个人化治疗建议和无缝设备连接，显着增强了数位呼吸机的效能。主导的演算法可以分析呼吸模式，并检测慢性阻塞性肺病 (COPD) 等疾病恶化的早期征兆，从而实现主动干预并降低住院风险。支援物联网的智慧吸入器和雾化器会自动将使用数据发送给医疗保健提供者，从而深入了解患者的服药依从性和处方药的有效性。此外，整合到呼吸设备中的语音数位助理可以加强病患教育，指导使用者正确的吸入技巧，并提供提醒以提高服药依从性。然而，人工智慧主导位呼吸机解决方案的成功取决于预测模型的准确性以及与医疗基础设施的互通性。随着人工智慧和物联网技术的不断发展，数位呼吸机有望在预测医学中发挥关键作用，并减轻全球慢性呼吸系统疾病的负担。

数位呼吸机可以改善儿科和老年护理吗？

管理儿童和老年人的呼吸系统疾病面临独特的挑战，包括难以坚持服药、对症状缺乏了解以及看护者依赖。具有即时监测功能的数位呼吸机已被证明在改善这些弱势群体的护理方面非常有效。儿科专用智慧吸入器和游戏化行动应用程式正在透过互动教程和基于奖励的参与方式帮助儿童了解吸入器的正确使用方法。同时，有误用吸入器或忘记服药时间表风险的老年患者可以从自动提醒、语音指导和远距医生咨询中受益。数位呼吸机解决方案还为看护者提供即时健康数据，以便在症状恶化时及时介入。儘管取得了这些进展，但在儿科和老年护理中采用数位呼吸机仍面临成本限制、可用性问题以及老年人群的数位落差等障碍。然而，随着医疗保健系统推动个人化护理和居家照护，预计数位呼吸机将在所有年龄层的慢性呼吸系统疾病管理中得到更广泛的接受。

推动数位呼吸市场成长的因素有哪些？

数位呼吸市场的成长受到多种因素的推动，包括呼吸系统疾病盛行率的上升、人工智慧和物联网医疗解决方案的进步，以及远端患者监护系统的兴起。全球价值导向医疗的趋势正在鼓励医疗服务提供者采用数位工具来改善患者预后并减少再入院率。数位疗法的监管核准和智慧呼吸设备的报销政策进一步推动了该技术的普及。呼吸监测与远端保健平台的整合，扩大了肺科专家的诊疗覆盖率，提高了诊断效率，并减轻了医疗机构的负担。此外，消费者对主动呼吸健康管理意识的不断增强，以及具有肺量计功能的可穿戴设备使用率的不断提高，也推动了市场的成长。儘管面临设备成本高昂、资料隐私问题以及需要与医院IT系统无缝整合等挑战，数位呼吸市场仍有望透过为慢性病管理和预防医学提供创新解决方案来实现显着成长。

部分

产品（智慧吸入器和雾化器、感测器和应用程式）、适应症（气喘、慢性阻塞性肺病、其他疾病）、分销管道（医院药房、零售药房、线上药房）、最终用户（医院最终用户、居家照护机构最终用户、其他最终用户）

受访公司范例

• 3M Health Care
• Adherium Limited
• Amiko Digital Health Limited
• AstraZeneca
• Becton, Dickinson and Company
• Boehringer Ingelheim
• Cognita Labs
• Cohero Health Inc.
• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE Healthcare
• GlaxoSmithKline plc（GSK）
• Hill-Rom Holdings, Inc.
• Medtronic plc
• Merck & Co., Inc.
• Novartis International AG
• Philips Respironics
• ResMed Inc.
• Teva Pharmaceutical Industries
• Vectura Group plc

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Digital Respiratory Devices Market to Reach US$313.3 Billion by 2030

The global market for Digital Respiratory Devices estimated at US$74.5 Billion in the year 2024, is expected to reach US$313.3 Billion by 2030, growing at a CAGR of 27.0% over the analysis period 2024-2030. Smart Inhalers & Nebulizers, one of the segments analyzed in the report, is expected to record a 29.8% CAGR and reach US$221.7 Billion by the end of the analysis period. Growth in the Sensors & Apps segment is estimated at 21.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.3 Billion While China is Forecast to Grow at 36.0% CAGR

The Digital Respiratory Devices market in the U.S. is estimated at US$20.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Billion by the year 2030 trailing a CAGR of 36.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 24.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.9% CAGR.

Global Digital Respiratory Devices Market - Key Trends & Drivers Summarized

Can Digital Respiratory Devices Improve Chronic Disease Management?

The rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis is driving the adoption of digital respiratory devices, revolutionizing patient monitoring and treatment adherence. Traditional inhalers and spirometers are now being integrated with digital sensors, Bluetooth connectivity, and cloud-based analytics, enabling real-time tracking of lung function, medication usage, and symptom patterns. Smart inhalers embedded with AI-powered adherence tracking technology alert patients and healthcare providers about missed doses, ensuring better disease management. Additionally, wearable respiratory monitors and remote spirometry solutions allow pulmonologists to assess patient lung health remotely, reducing hospital visits and emergency room admissions. However, while digital respiratory devices offer enhanced convenience and accuracy, concerns related to data security, device affordability, and integration with electronic health records (EHRs) remain key challenges. Despite these hurdles, the demand for digital respiratory solutions is expected to rise, particularly as healthcare systems increasingly prioritize remote patient monitoring and personalized treatment strategies.

How Is AI and IoT Shaping the Future of Respiratory Care?

Artificial intelligence (AI) and the Internet of Things (IoT) are significantly enhancing digital respiratory devices by enabling predictive analytics, personalized treatment recommendations, and seamless device connectivity. AI-driven algorithms analyze respiratory patterns to detect early signs of exacerbations in conditions like COPD, allowing for proactive intervention and reducing hospitalization risks. IoT-enabled smart inhalers and nebulizers automatically transmit usage data to healthcare providers, offering insights into patient adherence and effectiveness of prescribed medications. Additionally, voice-enabled digital assistants integrated into respiratory devices are enhancing patient education, guiding users on proper inhaler techniques, and offering reminders to improve medication compliance. However, the success of AI-driven digital respiratory solutions depends on the accuracy of predictive models and seamless interoperability with healthcare infrastructure. As AI and IoT technologies continue to evolve, digital respiratory devices are expected to play a crucial role in predictive healthcare, reducing the burden of chronic respiratory conditions worldwide.

Can Digital Respiratory Devices Improve Pediatric and Elderly Care?

Managing respiratory conditions in pediatric and elderly patients presents unique challenges, including difficulties in medication adherence, lack of symptom awareness, and caregiver dependence. Digital respiratory devices equipped with real-time monitoring capabilities are proving to be highly effective in improving care for these vulnerable populations. Pediatric-focused smart inhalers and gamified mobile applications are helping children understand proper inhaler usage through interactive tutorials and rewards-based engagement. Meanwhile, elderly patients, who are often at risk of misusing inhalers or forgetting medication schedules, benefit from automated reminders, voice-guided instructions, and remote physician consultations. Digital respiratory solutions also provide caregivers with access to real-time health data, enabling timely intervention in case of deteriorating symptoms. Despite these advancements, the adoption of digital respiratory devices in pediatric and geriatric care faces barriers such as cost constraints, usability concerns, and the digital divide among older populations. However, as healthcare systems push for personalized and home-based care, digital respiratory devices are expected to gain widespread acceptance in managing chronic respiratory conditions across all age groups.

What Is Driving the Growth of the Digital Respiratory Devices Market?

The growth in the digital respiratory devices market is driven by several factors, including the increasing prevalence of respiratory disorders, advancements in AI and IoT-enabled healthcare solutions, and the rise of remote patient monitoring systems. The global push toward value-based care is encouraging healthcare providers to adopt digital tools that enhance patient outcomes and reduce hospital readmissions. Regulatory approvals for digital therapeutics and reimbursement policies for smart respiratory devices are further boosting adoption. The integration of respiratory monitoring with telehealth platforms is expanding access to pulmonologists, improving diagnostic efficiency, and reducing the burden on healthcare facilities. Additionally, growing consumer awareness about proactive respiratory health management and the increasing use of wearables with spirometry capabilities are fueling market expansion. Despite challenges such as high device costs, data privacy concerns, and the need for seamless integration with hospital IT systems, the digital respiratory devices market is poised for substantial growth, offering innovative solutions for both chronic disease management and preventive care.

SCOPE OF STUDY:

The report analyzes the Digital Respiratory Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Smart Inhalers & Nebulizers, Sensors & Apps); Indication (Asthma, COPD, Other Diseases); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); End-Use (Hospitals End-Use, Homecare Settings End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• 3M Health Care
• Adherium Limited
• Amiko Digital Health Limited
• AstraZeneca
• Becton, Dickinson and Company
• Boehringer Ingelheim
• Cognita Labs
• Cohero Health Inc.
• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE Healthcare
• GlaxoSmithKline plc (GSK)
• Hill-Rom Holdings, Inc.
• Medtronic plc
• Merck & Co., Inc.
• Novartis International AG
• Philips Respironics
• ResMed Inc.
• Teva Pharmaceutical Industries
• Vectura Group plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Digital Respiratory Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Respiratory Diseases Drives Demand for Advanced Digital Respiratory Devices
  • Surge in Global Air Pollution and Environmental Hazards Expands Addressable Market for Respiratory Health Solutions
  • Rising Aging Populations and Associated Respiratory Conditions Propel Growth in Digital Respiratory Device Adoption
  • The Growing Focus on Telehealth and Remote Patient Monitoring Strengthens the Case for Digital Respiratory Devices
  • Technological Advancements in Wearable Health Devices Drive Innovation in Portable Digital Respiratory Monitoring Systems
  • Surge in Home Healthcare Solutions Expands Market Opportunities for Digital Respiratory Devices in Non-Hospital Settings
  • Integration of Artificial Intelligence and Machine Learning Enhances Diagnostic Accuracy and Treatment Plans in Digital Respiratory Devices
  • Increasing Consumer Awareness of Respiratory Health and Preventive Care Drives Market Demand for Home-Based Digital Solutions
  • Expansion of Smart Cities and Public Health Programs Accelerates Adoption of Digital Respiratory Devices in Air Quality Monitoring
  • Government Initiatives for Respiratory Health and Disease Management Propel Market Growth for Digital Respiratory Monitoring Solutions
  • Regulatory Advancements for Home Healthcare Devices Strengthen Adoption of Digital Respiratory Devices in Consumer Markets
  • The Rise of Connected Health Platforms Drives Demand for Digital Respiratory Devices with Integrated Data Analytics
  • The Growing Role of Digital Therapeutics and Personalized Medicine in Respiratory Care Expands Opportunities for Digital Devices
  • Increasing Focus on Improving Patient Outcomes and Reducing Hospital Readmissions Accelerates Adoption of Digital Respiratory Monitoring
  • Advancements in Battery Technology and Energy Efficiency Propel Growth in Portable Digital Respiratory Devices
  • Rising Incidence of Sleep Apnea and Sleep Disorders Strengthens Demand for Home Use Digital Respiratory Solutions
  • Increasing Availability of Digital Respiratory Devices in Emerging Markets Expands Global Market Reach
  • The Shift Toward Preventive and Early Diagnosis Models Drives Adoption of Digital Respiratory Devices for At-Risk Populations
  • Growing Investment in Respiratory Health Startups and Digital Health Solutions Fuels Market Innovation
  • Increased Collaboration Between Healthcare Providers and Tech Companies Expands Access to Digital Respiratory Monitoring Devices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Respiratory Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Respiratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Digital Respiratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Digital Respiratory Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Smart Inhalers & Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Smart Inhalers & Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Smart Inhalers & Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Sensors & Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Sensors & Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Sensors & Apps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Homecare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Homecare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Homecare Settings End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• JAPAN
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• CHINA
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• EUROPE
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Digital Respiratory Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Digital Respiratory Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• FRANCE
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• GERMANY
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Digital Respiratory Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• INDIA
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Digital Respiratory Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Digital Respiratory Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Digital Respiratory Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Digital Respiratory Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• AFRICA
  • Digital Respiratory Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Digital Respiratory Devices by Product - Smart Inhalers & Nebulizers and Sensors & Apps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Digital Respiratory Devices by Product - Percentage Breakdown of Value Sales for Smart Inhalers & Nebulizers and Sensors & Apps for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Digital Respiratory Devices by End-Use - Homecare Settings End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Digital Respiratory Devices by End-Use - Percentage Breakdown of Value Sales for Homecare Settings End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Digital Respiratory Devices by Indication - Asthma, COPD and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Digital Respiratory Devices by Indication - Percentage Breakdown of Value Sales for Asthma, COPD and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Digital Respiratory Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Digital Respiratory Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION